Orsulic et al have shown that p53-deficient ovarian cells engineered to overexpress multiple oncogenes, c-myc, Kras, and Akt, develop ovarian tumors when injected in mice [42]. The gene discussed is AKT1; the disease is ovarian neoplasm.